Skip to main content
TipRanks
Go Ultimate75% OFF

Medical Properties Trust (MPT) AI Stock Analysis

6,210 Followers
MPT

Medical Properties Trust

(NYSE:MPT)

Select Model
Rating:53Neutral
Price Target:$2.00â–²(14.29% Upside)
Action:reiterated
Date:11/17/26

The score is held back primarily by weak technicals (sharp downtrend and very poor momentum) and a leveraged, historically volatile financial profile despite a TTM improvement. Cheap valuation (low P/E and very high yield) and a generally constructive earnings call centered on rent collections and refinancing progress provide partial support, but tenant payment uncertainty and incomplete refinancing steps keep overall risk elevated.

Positive Factors
Recurring Rental RevenueMaintaining annualized cash rental revenue above $1 billion after substantial asset sales indicates a sizeable recurring lease base and effective capital recycling. Continued rent expectations above that level support visibility into operating cash generation and preserve the scale of MPT’s healthcare real estate platform.
Negative Factors
High LeverageDebt at roughly twice equity leaves MPT more exposed to refinancing costs, asset-value changes, and operating setbacks than a lightly levered owner. High leverage can constrain investment flexibility and make tenant or market disruptions more consequential for equity and cash-flow stability.

Medical Properties Trust (MPT) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%MPT-66.53%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.03B
Dividend Yield
20.57%
Average Volume (3M)
16.74M
Price to Earnings (P/E)
4.2
Beta (1Y)
0.77
Revenue Growth
10.53%
EPS Growth
―
Country
US
Employees
121
Sector
Real Estate
Sector Strength
65
Industry
REIT - Healthcare Facilities

Medical Properties Trust Business Overview & Revenue Model

Company Description

Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive...

How the Company Makes Money

MPT primarily makes money by owning hospital real estate and collecting contractual rent from healthcare operators that lease its facilities. Its main revenue stream is lease income (typically structured as long-term leases, commonly including annual...

Medical Properties Trust Earnings Call Summary

Earnings Call Date:Oct 29, 2026(Q3-2026)|% Change Since:-36.36%|Next Earnings Date:Feb 25, 2027
Earnings Call SentimentPositive

The call was broadly positive. Management highlighted cash rental revenue above the $1 billion target, strong performance across several European and U.S. operators, substantial asset monetization gains, and meaningful progress on debt refinancing and balance sheet flexibility. These positives outweighed challenges involving HSA's rent nonpayment and revenue cycle management, the 18% Priory rent reduction caused by NHS budget constraints, Colombia-related impairments, and the remaining uncompleted 2027 refinancing steps.

Positive Updates

Annualized Cash Rental Revenue Exceeds $1 Billion Target
MPT has collected more than $750 million of cash revenue year-to-date, which annualizes to more than the at least $1 billion target projected for year-end 2026. This was achieved despite selling 9 properties for approximately $600 million in cash proceeds, and the company continues to expect portfolio cash rents above $1 billion in 2027.

Negative Updates

HSA Rent Nonpayment and Revenue Cycle Challenges
HSA did not pay September rent, which caused normalized FFO to be below what it otherwise would have been. Management said HSA's core challenge remains revenue cycle management because the hospitals have not done a good enough job of billing and collecting, and MPT has not projected when rent collections will resume. MPT's loan to HSA is approximately $150 million.

Company Guidance

Management projected annualized cash rental revenue of at least $1 billion by the end of this year and continues to expect portfolio cash rents above $1 billion for 2027; NOR is currently paying 50% of contractual rent as scheduled and will begin paying 100% contractual rent in December. Priory’s annual rental obligations were reduced by approximately 18%, with rents able to increase as patient volumes recover, and MPT can extend the lease to 2055 at its discretion; the foregone rent starts at GBP 11 million that escalates. MPT expects to complete a new multiyear revolver in coming weeks, purposefully downsize the current revolver commitment of about $1.3 billion, and have no maturities until June 2028 when about $600 million of sterling bonds are due; further headroom is expected to be created up to 225%.

Medical Properties Trust Financial Statement Overview

Summary

TTM profitability and free cash flow have improved and are positive, supporting a turnaround narrative. However, results have been volatile across recent years and leverage remains high (debt ~2.0x equity), which elevates refinancing/tenant-risk sensitivity and reduces confidence in earnings durability.

Income Statement

56Neutral

Balance Sheet

45Neutral

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.03B972.02M995.55M871.80M1.54B1.54B
Gross Profit850.86M935.61M968.29M830.23M1.50B1.51B
EBITDA1.35B545.86M-1.49B340.24M1.67B1.46B
Net Income249.13M-277.05M-2.41B-556.48M902.60M656.02M
Balance Sheet
Total Assets14.39B15.00B14.29B18.30B19.66B20.52B
Cash, Cash Equivalents and Short-Term Investments599.28M540.86M332.33M250.02M235.67M459.23M
Total Debt9.26B9.83B8.98B10.22B10.41B11.37B
Total Liabilities9.77B10.39B9.46B10.67B11.06B12.07B
Stockholders Equity4.62B4.61B4.83B7.63B8.59B8.44B
Cash Flow
Free Cash Flow249.39M230.77M245.48M505.79M-801.35M746.11M
Operating Cash Flow249.39M230.77M245.48M505.79M739.01M811.66M
Investing Cash Flow429.19M-264.74M1.32B517.56M396.06M-3.86B
Financing Cash Flow-481.40M228.08M-1.48B-1.02B-1.34B2.95B

Medical Properties Trust Technical Analysis

Technical Analysis SentimentNegative
Last Price1.75

Price Trends

50DMA2.75Negative
100DMA3.51Negative
200DMA4.17Negative

Market Momentum

MACD-0.35Negative
RSI29.96Positive
STOCH47.13Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MPT, the sentiment is Negative. The current price of 1.75 is below the 20-day moving average (MA) of 1.99, below the 50-day MA of 2.75, and below the 200-day MA of 4.17, indicating a bearish trend. The MACD of -0.35 indicates Negative momentum. The RSI at 29.96 is Positive, neither overbought nor oversold. The STOCH value of 47.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MPT.

Medical Properties Trust Risk Analysis

Medical Properties Trust disclosed 53 risk factors in its most recent earnings report. Medical Properties Trust reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.As a result of the Quarterly Report on Form 10-Q for the period ended March 31, 2024, not being filed timely, we are currently ineligible to file a new short-form registration statement on Form S-3 for sales of securities, including under an ATM program, which may impair our ability to raise capital on terms favorable to us, in a timely manner or at all.Q4, 2024
2.Declines in the fair value of our assets may force us to recognize impairment charges, which could adversely impact our financial condition, liquidity and results of operations.Q4, 2024
3.Regulatory restrictions on REIT transactions could adversely affect our business.Q4, 2024

Medical Properties Trust Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

MPT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AHRAHR77Outperform$13.48B117.262.40%1.74%21.48%243.69%
VTRVTR70Outperform$47.00B160.331.87%2.36%22.13%0.00%
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
DOCDOC63Neutral$13.56B35.635.00%6.34%9.42%―
UHTUHT61Neutral$516.51M25.4913.83%8.03%-0.02%12.24%
HRHR58Neutral$6.55B-136.05-1.04%4.96%-6.28%77.63%
MPTMPT53Neutral$965.80M4.195.45%20.57%10.53%―

* Real Estate Sector Average

Performance Comparison

-50%-25%0%25%MPTDOCVTRHRUHTAHRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MPT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MPTMedical Properties Trust, Inc.1.75-3.17-64.45%
DOCHealthpeak Properties, Inc.19.242.5215.05%
VTRVentas Inc86.559.6412.54%
HRHealthcare Realty Trust Incorporated19.362.2713.30%
UHTUniversal Health Realty37.22-0.02-0.05%
AHRAmerican Healthcare REIT, Inc.57.549.7220.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026